U.S. Biotech Stock News

In recent announcements, Centuri Holdings reported securing more than US$870,000,000 in new commercial awards and bookings across North America, with roughly four-fifths tied to renewals of existing Master Service Agreements and the remainder from new contracts and strategic bids with investor-owned utilities. Beyond the headline figure, the mix of long-term MSA renewals and new regional wins in the Southwest and Midwest highlights Centuri’s embedded role in utility infrastructure work while...

EverCommerce (EVCM) has quickly come into focus after a 19% share price drop linked to a revenue miss, reduced full year guidance, an AI acquisition, and a larger share repurchase plan. See our latest analysis for EverCommerce. At a share price of $12.07, EverCommerce’s recent 19% drop sits against a 30 day share price return of 21.06% and a 90 day share price return of 11.97%. The 1 year total shareholder return of 14.95% and 3 year total shareholder return of 40.35% point to momentum that...

Federated Hermes, Inc. has announced that long-time fixed income executive R.J. Gallo will assume the role of global fixed income CIO and Ann Ferentino will become sole head of the Municipal Bond Group following current CIO Robert Ostrowski’s planned retirement on May 1, 2026, realigning oversight of US$101.80 billion in fixed income assets. The planned transition concentrates leadership of both global fixed income and municipal strategies in two long-tenured insiders, signaling an emphasis...

In recent coverage, Pool Corporation, a leading distributor of swimming pool supplies and leisure products, was highlighted for a return to sales and earnings growth after prior declines, alongside an improving free cash flow profile. Analysts and commentators also pointed to Pool’s steadily growing dividend, low payout ratio, and greater financial flexibility, underlining the company’s capacity to support future dividend increases, buybacks, or reinvestment without overstretching its...

Avery Dennison (AVY) is back in focus after fiscal Q3 2025 results topped analyst expectations on adjusted EPS and revenue, and management issued an upbeat adjusted EPS outlook for Q4 2025. See our latest analysis for Avery Dennison. The upbeat Q3 release and Walmart RFID partnership have coincided with a 17.24% 90 day share price return and a US$186.02 share price, while the 5 year total shareholder return of 24.99% points to steadier long term compounding rather than surging momentum. If...

In recent days, Brinker International has attracted renewed attention from Wall Street as several major firms upgraded their ratings and raised expectations, citing strong operating momentum at its Chili’s chain and effective menu enhancements. This wave of analyst optimism underscores how Chili’s same-store sales gains and brand execution are increasingly shaping perceptions of Brinker’s longer-term relevance in casual dining. We’ll now explore how this cluster of analyst upgrades, centered...

Zenas BioPharma recently announced positive results from its Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease, highlighting a key clinical milestone for this rare autoimmune condition. The update also underscored extensive operational, financing, regulatory, and geopolitical risks, including reliance on China-based manufacturing partners and collaborators, that continue to shape the company’s outlook. Next, we’ll assess how the positive Phase 3 INDIGO data for...

Liberty Energy (LBRT) just announced a new partnership with Vantage Data Centers to supply utility scale, high efficiency power for North American data centers, including cloud and AI workloads, with capacity reserved through 2027. See our latest analysis for Liberty Energy. The Vantage partnership arrives after a 90-day share price return of 58.09%, even though the 1-year total shareholder return is 8.67% lower. Recent momentum has therefore been building from a softer longer-term base. If...

On 8 January 2026, Guidewire Software, Inc. announced that its Board had authorized a new US$500,000,000 share repurchase program, to be funded from existing cash, working capital, or operating cash flows, following the completion of a prior US$400,000,000 buyback under which 4,705,840 shares, or 5.63% of shares outstanding, were retired. This renewed commitment to repurchases, alongside the recent completion of an earlier plan, underlines management’s emphasis on capital return and balance...

Atkore (ATKR) is back in focus after its latest earnings update, as investors weigh disciplined capital deployment, efficiency efforts, and a rational pricing backdrop against lingering questions around potential margin normalization. See our latest analysis for Atkore. Atkore’s recent earnings update comes as the stock shows short term momentum, with a 30 day share price return of 7.07% and a 90 day gain of 10.19%, while the 1 year total shareholder return of 16.39% decline and 3 year total...

Parsons (PSN) recently secured a ten year, US$392 million single award contract from a federal customer, a fresh mandate that puts its biometrics and network engineering capabilities in the spotlight after earlier contract setbacks. See our latest analysis for Parsons. The new federal contract arrives after a stretch where Parsons’ 90 day share price return of 20.59% contrasts with a 9.58% share price gain year to date. Its 1 year total shareholder return of 25.79% sits alongside a 52.06%...

BXP announced that it had signed an approximately 275,000 square foot, 20-year lease with Starr for its under-construction 343 Madison Avenue office tower in Midtown Manhattan, where Starr will occupy floors 16 through 27 as its New York headquarters with delivery targeted for late 2029. This long-duration anchor lease highlights ongoing tenant appetite for high-end, sustainability-focused office space in prime Manhattan locations, reinforcing BXP’s role among premier office REITs. We’ll now...

In recent days, Raymond James upgraded The Estée Lauder Companies to “Strong Buy,” citing improving demand trends, brand momentum, and operational efficiencies ahead of the company’s upcoming second-quarter earnings release. Analysts’ growing confidence in a turnaround, supported by Estée Lauder’s history of outperforming prior earnings expectations and a forecast for a multi‑year profit recovery, is reshaping investor perceptions of the business. We’ll now examine how this Raymond James...

In recent days, United Natural Foods director James C. Pappas acquired 17,000 shares in an insider purchase worth over US$500,000, reinforcing leadership’s commitment to the company’s plans for modest sales growth, EBITDA expansion, and stronger free cash flow outlined at its Investor Day. This insider buying, against a backdrop of mixed views on the 2026 food retail sector, has become a focal point for investors weighing UNFI’s long-term execution against broader industry challenges. Now...

Hagerty stock reacts to Schumacher F1 car auction spotlight Hagerty (HGTY) is back in focus after subsidiary Broad Arrow put Michael Schumacher’s 1992 Benetton B192-05 Formula One car into its Global Icons: Europe Online Auction, drawing fresh attention to the company’s collector car ecosystem. See our latest analysis for Hagerty. The Schumacher auction arrives as Hagerty’s share price trades at $13.22, with a 1 month share price return of 5.34% and a 90 day share price return of 13.09%. The...

SS Innovations International (SSII) has paired a new set of 5-millimeter robotic surgical instruments with a senior leadership change, appointing Milan Rao as Global Chief Operating Officer and Chief Financial Officer to support its next phase of scaling. See our latest analysis for SS Innovations International. Despite the product update and leadership change, the current share price of US$5.60 comes after a 30 day share price return of a 7.13% decline and a 90 day share price return of a...

Why TaskUs Stock Is Back on Investors’ Radar TaskUs (TASK) has attracted fresh attention after recent performance data highlighted mixed returns across different timeframes, prompting investors to reassess the outsourcing specialist’s valuation and business momentum. See our latest analysis for TaskUs. Recent trading has been steady rather than dramatic, with a modest 1-day share price return of 1.11% and year to date share price return of 3.85%. This is set against a weaker 1-year total...

Cogent Biosciences (COGT) has drawn fresh attention after submitting a New Drug Application to the FDA for bezuclastinib in NonAdvanced Systemic Mastocytosis, supported by statistically significant SUMMIT trial data and its prior Breakthrough Therapy Designation. See our latest analysis for Cogent Biosciences. The share price sits at $35.57 after a 90 day share price return of 118.62%, while the 1 year total shareholder return of 338.59% points to strong momentum building around bezuclastinib...

Installed Building Products, Inc. recently priced a US$500,000,000 offering of 5.625% senior unsecured notes due 2034, primarily to redeem its existing 5.75% senior unsecured notes due 2028 and cover related costs in a private placement under Rule 144A and Regulation S. This refinancing, paired with a recent S&P Global Ratings upgrade of the company’s credit rating, highlights a more flexible balance sheet and potentially lower long-term financing costs. Now we’ll examine how IBP’s new 2034...

COPT Defense Properties (CDP) is back in focus after reporting 557,000 square feet of vacancy leasing in 2025, topping its latest target, along with new build-to-suit projects in Maryland and Texas. See our latest analysis for COPT Defense Properties. The recent leasing wins and build to suit projects appear to have caught investors' attention, with a 1 day share price return of 4.57% to US$29.51 and a 7.35% year to date share price return. The 5 year total shareholder return of 39.94% points...

Recent attention on Diebold Nixdorf (DBD) centers on its post restructuring rebound. Improving sentiment is tied to upcoming earnings expectations, contract renewals, software upgrades, and a focus on retail automation and cost discipline. See our latest analysis for Diebold Nixdorf. At a share price of $68.0, Diebold Nixdorf has paired a sharp early year setback with a 90 day share price return of 23.86%, while the 1 year total shareholder return of 61.64% signals momentum building around...

Western Alliance Bancorporation: Recent Returns in Focus Western Alliance Bancorporation (WAL) has drawn fresh attention as investors weigh its recent share performance, with the stock showing positive moves over the past week, month, past 3 months, and year. See our latest analysis for Western Alliance Bancorporation. The 1-year total shareholder return of 13.2% sits on top of strong recent momentum, with a 90-day share price return of 19.7%. This suggests investors are reassessing both...

Fortrea Holdings recently announced that its CEO, CFO, and SVP of Investor Relations participated in the J.P. Morgan Annual Healthcare Conference on January 13, 2025, presenting the business and taking investor questions via a webcasted session. At the same time, a series of more positive analyst views and higher earnings estimates have drawn fresh attention to Fortrea’s position in the global contract research market. We’ll now examine how the recent wave of analyst upgrades and earnings...

MUSC Health’s new multi year partnership with Baxter International (BAX) to deploy connected care technologies has pushed the stock into focus, as investors weigh what deeper bedside integration could mean for the business. See our latest analysis for Baxter International. The MUSC Health agreement lands at a time when sentiment around Baxter is trying to find its footing, with a 13.9% 1 month share price return and a 6.1% year to date share price return contrasting with a 28.8% 1 year total...